FDA Approves Inovio Voceryq Treatment for Rare Throat Disease in First Company Approval
WASHINGTON — The U.S. Food and Drug Administration on Friday, October 30, 2026, approved Inovio Pharmaceuticals’ treatment for a rare respiratory condition that causes wart-like growths in the airways, marking…